Insider Transactions in Q1 2021 at Inari Medical, Inc. (NARI)
Insider Transaction List (Q1 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 26
2021
|
Thomas Tu Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
5,000
-1.97%
|
$515,000
$103.13 P/Share
|
|
Mar 26
2021
|
Thomas Tu Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+10.13%
|
$0
$0.46 P/Share
|
|
Mar 19
2021
|
Andrew Hykes President and CEO |
SELL
Open market or private sale
|
Direct |
9,000
-0.82%
|
$981,000
$109.3 P/Share
|
|
Mar 17
2021
|
Andrew Hykes President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+8.23%
|
$0
$0.43 P/Share
|
|
Mar 16
2021
|
Donald B Milder Director |
SELL
Bona fide gift
|
Indirect |
210,000
-4.38%
|
-
|
|
Mar 16
2021
|
Presidio Management Group X LLC > 10% Shareholder |
BUY
Other acquisition or disposition
|
Indirect |
763,123
+37.07%
|
-
|
|
Mar 16
2021
|
Presidio Management Group X LLC > 10% Shareholder |
SELL
Other acquisition or disposition
|
Indirect |
3,389,513
-66.67%
|
-
|
|
Mar 16
2021
|
Jonathan D Root Director |
BUY
Other acquisition or disposition
|
Direct |
94,101
+18.03%
|
-
|
|
Mar 16
2021
|
Jonathan D Root Director |
SELL
Other acquisition or disposition
|
Indirect |
3,389,513
-66.67%
|
-
|
|
Mar 16
2021
|
Jonathan D Root Director |
BUY
Other acquisition or disposition
|
Indirect |
685,827
+50.0%
|
-
|
|
Mar 15
2021
|
William Hoffman Director |
SELL
Bona fide gift
|
Direct |
2,165
-0.23%
|
-
|
|
Mar 15
2021
|
Gilde Healthcare Iv U.A. Cooperatieve > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
1,200,000
-3.11%
|
$138,000,000
$115.03 P/Share
|
|
Mar 12
2021
|
Gilde Healthcare Iv U.A. Cooperatieve > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
250,000
-0.71%
|
$29,250,000
$117.43 P/Share
|
|
Mar 12
2021
|
Kirk G. Nielsen Director |
SELL
Open market or private sale
|
Direct |
206
-0.44%
|
$24,720
$120.0 P/Share
|
|
Mar 11
2021
|
Kirk G. Nielsen Director |
SELL
Other acquisition or disposition
|
Indirect |
721,574
-100.0%
|
-
|
|
Mar 11
2021
|
Kirk G. Nielsen Director |
BUY
Other acquisition or disposition
|
Direct |
7,955
+14.6%
|
-
|
|
Mar 11
2021
|
Kirk G. Nielsen Director |
BUY
Other acquisition or disposition
|
Indirect |
147,021
+50.0%
|
-
|
|
Mar 10
2021
|
Donald B Milder Director |
SELL
Open market or private sale
|
Indirect |
7,000
-0.02%
|
$812,000
$116.61 P/Share
|
|
Mar 09
2021
|
Hill, Mitch C. Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
5,000
-1.4%
|
$480,000
$96.94 P/Share
|
|
Mar 09
2021
|
Hill, Mitch C. Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+6.39%
|
$0
$0.46 P/Share
|
|
Mar 05
2021
|
William Hoffman Director |
SELL
Open market or private sale
|
Direct |
30,000
-0.33%
|
$2,760,000
$92.88 P/Share
|
|
Feb 26
2021
|
Thomas Tu Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
5,000
-2.93%
|
$515,000
$103.16 P/Share
|
|
Feb 26
2021
|
Thomas Tu Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+10.13%
|
$0
$0.46 P/Share
|
|
Feb 19
2021
|
Andrew Hykes President and CEO |
SELL
Open market or private sale
|
Direct |
9,000
-0.86%
|
$1,053,000
$117.44 P/Share
|
|
Feb 11
2021
|
Hill, Mitch C. Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
10,690
+13.55%
|
-
|
|
Feb 11
2021
|
Thomas Tu Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
10,690
+21.61%
|
-
|
|
Feb 11
2021
|
William Hoffman Director |
BUY
Grant, award, or other acquisition
|
Direct |
21,380
+1.85%
|
-
|
|
Feb 11
2021
|
Andrew Hykes President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
16,030
+7.03%
|
-
|
|
Feb 10
2021
|
Donald B Milder Director |
SELL
Open market or private sale
|
Indirect |
7,000
-0.03%
|
$798,000
$114.58 P/Share
|
|
Feb 09
2021
|
Hill, Mitch C. Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
5,000
-1.64%
|
$570,000
$114.58 P/Share
|
|
Feb 09
2021
|
Hill, Mitch C. Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+7.41%
|
$0
$0.46 P/Share
|
|
Feb 05
2021
|
William Hoffman Director |
SELL
Open market or private sale
|
Direct |
30,000
-0.44%
|
$3,330,000
$111.95 P/Share
|
|
Jan 27
2021
|
Thomas Tu Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
5,000
-1.62%
|
$495,000
$99.68 P/Share
|
|
Jan 27
2021
|
Thomas Tu Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+13.13%
|
$0
$0.46 P/Share
|
|
Jan 20
2021
|
William Hoffman Director |
SELL
Open market or private sale
|
Direct |
20,000
-0.58%
|
$2,020,000
$101.33 P/Share
|
|
Jan 20
2021
|
Thomas Tu Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
12,000
-15.4%
|
$1,200,000
$100.92 P/Share
|
|
Jan 20
2021
|
Thomas Tu Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
12,000
+23.04%
|
$0
$0.46 P/Share
|
|
Jan 19
2021
|
Andrew Hykes President and CEO |
SELL
Open market or private sale
|
Direct |
9,000
-0.3%
|
$864,000
$96.6 P/Share
|
|
Jan 13
2021
|
Kirk G. Nielsen Director |
SELL
Other acquisition or disposition
|
Indirect |
1,082,364
-73.33%
|
-
|
|
Jan 13
2021
|
Kirk G. Nielsen Director |
BUY
Other acquisition or disposition
|
Direct |
11,933
+23.63%
|
-
|
|
Jan 13
2021
|
Kirk G. Nielsen Director |
BUY
Other acquisition or disposition
|
Indirect |
220,532
+50.0%
|
-
|
|
Jan 13
2021
|
Andrew Hykes President and CEO |
SELL
Open market or private sale
|
Direct |
27,600
-2.49%
|
$2,622,000
$95.66 P/Share
|
|
Jan 13
2021
|
Hill, Mitch C. Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
36,000
-14.19%
|
$3,276,000
$91.23 P/Share
|
|
Jan 13
2021
|
Hill, Mitch C. Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
36,000
+27.8%
|
$0
$0.46 P/Share
|
|
Jan 13
2021
|
William Hoffman Director |
SELL
Open market or private sale
|
Direct |
30,000
-0.84%
|
$2,730,000
$91.22 P/Share
|
|
Jan 11
2021
|
Donald B Milder Director |
SELL
Open market or private sale
|
Indirect |
7,000
-0.05%
|
$588,000
$84.18 P/Share
|
|
Jan 08
2021
|
Hill, Mitch C. Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
5,000
-2.74%
|
$410,000
$82.87 P/Share
|
|
Jan 05
2021
|
Andrew Hykes President and CEO |
SELL
Open market or private sale
|
Direct |
27,600
-1.85%
|
$2,208,000
$80.44 P/Share
|
|
Jan 04
2021
|
Kirk G. Nielsen Director |
SELL
Other acquisition or disposition
|
Indirect |
1,082,362
-58.33%
|
-
|
|
Jan 04
2021
|
Kirk G. Nielsen Director |
BUY
Other acquisition or disposition
|
Direct |
11,932
+30.94%
|
-
|